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ABSTRACT
Background Data on diseases’ determinants and health status of asylum seekers (ASs) are limited.
Methods We performed a cross-sectional retrospective study in a large ASs centre in Italy. Data were collected during a 1-year period. Descriptive
statistics were calculated. A x2 test was used to assess the association between socio-demographics characteristics of ASs and screening test
results. A multiple logistic regression analysis was performed to identify diseases’ predictors by using ICD-10 diagnoses classification as outcome
variable, socio-demographic characteristics as independent variable and visits’ number as confounding variable.
Results Overall, data on 792 ASs (mean age 27 years, 80% males, 58% from Africa) were assessed, 43% underwent voluntary infectious
diseases screening and 2843 diagnoses were recorded. The most frequent diagnoses were: respiratory diseases, symptoms/signs not elsewhere
classified, digestive diseases and infectious diseases. Gender was the most frequent predictor of ICD-10 diagnoses, while African origin, civil
status and education were, respectively, predictive of cardiovascular and infectious diseases, genitourinary diseases and pregnancy-related
disorders. Higher mean age was associated with syphilis, HIV and HCV infection and African origin with HIV infection.
Conclusions Communicable diseases were not prevalent in the ASs population we analysed. A stronger cultural mediation support is needed to
facilitate prevention, access and continuity of care for ASs.
Keywords asylum seekers, healthcare, migration, infectious diseases screening
Introduction
According to United Nations (UN) agencies, there are .10
million refugees (80% hosted in developing countries).1,2
During 2013, a total of 612 700 new asylum applications were
registered in the 44 industrialized countries, 65% in the
European Union (EU) countries, with a significant increase
(þ32%) of claims, mostly related to the ongoing war in
Syria.3 In 2013, the main receiving industrialized countries
were: Germany (18%), USA (14%), France (10%), Sweden
(9%), Turkey (7%), UK and Italy (5%).3
In Italy, an asylum seeker (AS) is a person who applies for
asylum status, while a refugee is a person who is granted
asylum status.4 The majority of asylum applications in Italy
are from migrants arriving by sea3: after the peak related to
the North African ‘Arab spring’ in 2011 (34 100 claims), there
was a drop in 2012 (17 350 claims) and an increase in 2013
(27 830 claims).3 The popular press often depicts migrants by
sea in defamatory terms, even if .70% of them have the
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right to apply for protection. Moreover, foreigners staying in
Italy for humanitarian reasons account for 1.8% of the
foreign-born persons living in the country and 0.13% of the
total resident population.5
In agreement with EU legislation (Dublin Regulation), ASs
who reach the EU must remain in the first country of entry
until their request is finalized, even if this country is not their
final destination. According to Italian laws, during the evalu-
ation of asylum application, ASs can be hosted in Asylum
Seekers Centres (ASCs), where they receive social, health and
legal assistance—currently, there are nine ASCs in Italy.
Moreover, ASs have free access to the public health system, al-
though language barriers often hamper their use.6 During the
dwell time in the ASCs, although there are no formal obliga-
tions, ASs are advised to consult the internal healthcare facil-
ity (IHCF) to evaluate their medical condition and allow
appropriate management of any health needs. In Italy, there
are no guidelines for health management of migrants hosted
in ASCs, even if the dwell time can reach 9–12 months.
The aim of our study is to describe the health profile of
ASs hosted in the ASC of Castelnuovo di Porto (Rome, Italy)
and to investigate diseases’ predictors, in order to implement
health assistance to this vulnerable group. For this purpose,
we performed a retrospective analysis of data from the IHCF
database recorded during a 1-year period.
Methods
The present work is a cross-sectional retrospective study
that analyses data collected at the IHCF of the ASC of
Castelnuovo di Porto (Rome, Italy) during a 1-year period
(March 2012–February 2013). According to the internal pro-
cedure, each AS who accessed to the IHCF for the first time
was interviewed through a standardized questionnaire
focused on socio-demographic data and medical history. The
interview was performed by the physician with the support
(when available) of mediators speaking the patient’s mother
tongue, with minors, the parent/carer was interviewed.
Countries of birth were classified as geographic macro-areas
according to the UN Statistic Division.7 Based on physical
examination findings, individual diagnosis for each visit was
recorded according to the International Classification of
Diseases (ICD-10). Psychiatric disorders were not included in
the study.
In order to avoid an over-estimation of chronic diseases
prevalence, all accesses by a same patient for the same reason,
occurred within a short-time period, were counted as single
record.
Infectious diseases screening was offered to all adults (18
years) examined. After receiving informed consent, screening
tests were performed in external laboratories. Hepatitis B virus
surface antigen (HBsAg) and antibody (HBsAb), hepatitis C
virus antibody (HCV-Ab) and human immunodeficiency virus
antibody (HIV-Ab) were detected by a third-generation enzyme-
linked immunoassay (ELISA). HIV-Ab-positive tests were con-
firmed by western blot. Screening for hepatitis B was based on
two determinations of HBsAg and HBsAb during a 6-month
period. Venereal Disease Research Laboratory (VDRL) and
Treponema pallidum particle agglutination assay (TPHA) were also
carried out. All positive screened cases were referred to public
hospitals for follow-up. For tuberculosis (TB) diagnosis and sur-
veillance, an internal algorithm8 based on clinical and anamnes-
tic evidences was applied, but no active screening was realized.
Descriptive statistics were used to assess socio-demographic
characteristics, screening tests results and ICD-10 diagnosis.
Results were also expressed as mean and standard deviation
(+SD). For each screening test, the prevalence was computed
with 95% confidence interval (95% CI) and a x2 test was used
to detect differences between groups and predictive indices.
Multiple logistic regression analysis was performed to identify
diseases’ predictors of clinical diagnosis using: (i) the ICD-10
diagnosis as an outcome variable; (ii) the socio-demographic
characteristics (birth country, age, gender, education, civil
status, occupation, tobacco and alcohol consumption) as inde-
pendent variable; (iii) the medical examinations’ number as
confounding variable. Analyses were carried out using Stata
10.1 software—P , 0.05 were considered statistically signifi-
cant. All activities were performed at the request of the AS, re-
gardless of the refugee status application and does not affect it.
The public authority (Prefecture of Rome) in charge of the
ASC approved data collection and use. The study was carried
out according to the Helsinki Declaration. Ethical approval was
not required because the study was based on data routinely col-
lected and stored according to the Italian law on privacy.
Results
Socio-demographic characteristics of the
population study
During the study period, the ASC housed a total of 1151 ASs
(excluding 161 ASs housed for ,1 week), of which 7.6%
were children (,14 years old). The mean length of stay at the
ASC was 268 days per person and the monthly average of
ASs present was 607 (525–649). The study population was
792 ASs (79.9% males), including 64 children, examined at
the IHCF during the study period. Table 1 summarizes the
socio-demographic characteristics of the population study.
Overall, 2843 individual diagnoses were reported, together
with 26 328 nursing activities, including administration of
drugs by DOT (Directly Observed Therapy).
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Table 1 Demographic characteristics of ASs (n ¼ 792)
Characteristics Africa Asia America Total
Westa Eastb Northc Centrald Southe Westf Southg
Gender
M (%) 238 (80.4) 60 (57.1) 29 (61.7) 11 (68.8) 216 (98.2) 78 (74.3) 1 (33.3) 633 (79.9)
F (%) 58 (19.6) 45 (42.9) 18 (38.3) 5 (31.2) 4 (1.9) 27 (25.7) 2 (66.7) 159 (20.1)
Total (%) 296 (37.4) 105 (13.3) 47 (5.9) 16 (2) 220 (27.8) 105 (13.3) 3 (0.4) 792 (100)
Age
Mean age (+SD) 27.6 (+9.1) 26.8 (+8.4) 25 (+13.2) 33.7 (+8.8) 27.6 (+7.8) 26.7 (+11.3) 29 (+14.2) 27.4 (+9.4)
Number of visits
Per person 3.7 2.9 4.2 3.2 3.6 3.4 2.3 3.6
Total (%) 1108 (39) 314 (11) 199 (7) 52 (1.8) 800 (28.1) 363 (12.8) 7 (0.3) 2843 (100)
Educationh
Available data (%) 124 (48.3) 57 (57.6) 19 (54.3) 15 (62.5) 110 (51.4) 37 (42.5) 2 (100) 364 (49.9)
Yes 89 (71.8) 43 (75.4) 18 (94.7) 14 (93.3) 91 (82.7) 35 (94.6) 2 (100) 292 (80.2)
No 35 (28.2) 14 (24.6) 1 (5.3) 1 (6.7) 19 (17.3) 2 (5.4) 0 (0) 72 (19.8)
Mean years (+SD) 5.6 (+5.9) 5.8 (+5.0) 7.8 (+6.7) 12 (+4.6) 7.0 (+5.5) 8.4 (+5.0) 12.0 (+0) 6.7 (+5.7)
Missing data (%) 144 42 (42.4) 16 (45.7) 9 (37.5) 104 (48.6) 50 (57.5) 0 (0) 365 (50.1)
Marital statush
Available data (%) 148 (55.2) 63 (63.6) 27 (77.1) 15 (62.5) 122 (57) 41 (47.1) 2 (100) 418 (57.3)
Married (%) 42 (28.4) 34 (54) 13 (48.2) 8 (53.3) 35 (28.7) 18 (43.9) 2 (100) 152 (36.3)
Unmarried (%) 99 (66.9) 29 (46) 14 (51.8) 7 (46.7) 87 (71.3) 23 (56.1) 0 (0) 259 (62)
Widow (%) 7 (4.7) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 7 (1.7)
Missing data (%) 120 (44.8) 36 (36.4) 8 (22.9) 9 (37.5) 92 (43) 46 (52.9) 0 (0) 311 (42.7)
Occupationh
Available data (%) 130 (48.3) 60 (60.6) 26 (74.3) 15 (62.5) 110 (51.4) 39 (45.3) 2 (100) 382 (52.4)
Craftsmen (%) 47 (36.1) 9 (15) 7 (26.9) 2 (13.3) 37 (33.6) 14 (35.9) 1 (50) 117 (30.6)
Trader (%) 28 (21.5) 7 (11.7) 5 (19.3) 1 (6.7) 23 (20.9) 3 (7.7) 0 (0) 67 (17.5)
Student (%) 11 (8.5) 7 (11.7) 1 (3.8) 4 (26.7) 12 (10.9) 3 (7.7) 0 (0) 38 (9.9)
Farmer (%) 13 (10) 2 (3.3) 1 (3.8) 0 (0) 12 (10.9) 1 (2.6) 0 (0) 29 (7.6)
Professional (%) 7 (5.4) 2 (3.3) 1 (3.8) 2 (13.3) 7 (6.4) 5 (12.8) 0 (0) 24 (6.3)
Military/police (%) 1 (0.8) 10 (16.7) 0 (0) 1 (6.7) 4 (3,7) 2 (5.1) 0 (0) 18 (4.8)
Public employee (%) 3 (2.3) 1 (1.6) 1 (3.8) 2 (13.3) 1 (0.9) 0 (0) 1 (50) 9 (2.4)
Unemployed (%) 20 (15.4) 22 (36.7) 10 (38.6) 3 (20) 14 (12.7) 11 (28.2) 0 (0) 80 (20.9)
Missing data (%) 139 (51.7) 39 (39.4) 9 (25.7) 9 (37.5) 104 (48.6) 47 (54.7) 0 (0) 347 (47.6)
Tobacco (daily)h
Available data (%) 88 (29.8) 60 (60.6) 20 (57.1) 8 (33.3) 100 (46.7) 35 (40.2) 2 (100) 313 (42.9)
Yes (%) 20 (22.7) 8 (13.3) 7 (35) 2 (25) 39 (39) 15 (42.8) 0 (0) 91 (29.1)
No (%) 68 (77.3) 52 (86.7) 13 (65) 6 (75) 61 (61) 20 (57.2) 2 (100) 222 (70.9)
Missing 180 (70.2) 39 (39.4) 15 (42.9) 16 (66.7) 114 (53.3) 52 (59.8) 0 (0) 416 (57.1)
Alcohol (1 alcoholic unit/day)h
Available data (%) 88 (29.8) 60 (60.6) 20 (57.1) 8 (33.3) 100 (46.7) 35 (40.2) 2 (100) 313 (42.9)
Yes (%) 12 (13.6) 2 (3.3) 3 (15) 3 (37.5) 9 (9) 11 (31.4) 2 (100) 42 (13.4)
No (%) 76 (86.4) 58 (96.7) 17 (85) 5 (62.5) 91 (91) 24 (68.6) 0 (0) 271 (86.6)
Missing 180 (70.2) 39 (39.4) 15 (42.9) 16 (66.7) 114 (53.3) 52 (59.8) 0 (0) 416 (57.1)
aBurkina Faso, Cameroon, Gambia, Ghana, Guinea, Ivory Coast, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, Sierra Leone, Togo.
bEritrea, Ethiopia, Kenya, Somalia.
cEgypt, Libya, Morocco, Sudan, Tunisia.
dGabon, Democratic Republic of Congo.
eAfghanistan, Bangladesh, India, Iran, Pakistan, Sri Lanka.
fArmenia, Georgia, Jordan, Iraq, Lebanon, Palestina, Syria, Turkey, Yemen.
gColombia.
hIncluding only adults (n ¼ 729).
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Study population mean age was 27.4 years. ASs were from
43 different countries, the most represented birth countries
were: Pakistan (13.1%), Nigeria (12.4%), Afghanistan (10.9%)
and Eritrea (7.6%). Among adult ASs (n ¼ 729), data on edu-
cation, civil status, occupation in the birth country and
tobacco/alcohol consumption were reported, respectively, for
364 (49.9%), 418 (57.3%), 382 (52.4%) and 313 (42.9%) par-
ticipants. The majority of adult ASs was schooled (80.2%),
with a mean of 6.7 years of education, unmarried (62%) and
employed (79%). Among adults, 91 participants (29.3%)
reported tobacco smoking (93.4% males) with an average of
11.2 (+7.9) cigarettes/day, 42 (13.5%) to consume alcohol
daily (83.3% males) and 22 (16.5%) to consume both regular-
ly. On a monthly basis, 39% of ASs requested a medical visit.
Among the 792 ASs examined at the IHCF, 391 (49.3%)
arrived at the ASC during the 1-year observation period and
their first medical visit occurred within 1 month of entry for
51.9% (203/391), between 2 and 3 months for 31.2% (122/
391) and after the third month for 16.9% (66/391) of the
cases.
Diagnostic groups and multiple regression analysis
Table 2 summarizes the diagnoses recorded during the study
period, respiratory diseases were the most frequently reported
(26.3%) showing a seasonal pattern of prevalence (October–
February). Diseases for the digestive system accounted for
11.6% of total diagnoses, and an additional 5.6% (160/2843)
was referable to digestive symptoms/signs not elsewhere clas-
sified. Infectious diseases ranked the fourth more frequent
ICD-10 diagnostic group. Infectious enteritis was the most
frequent infectious disease, due to a cluster of 41 cases related
to food contamination. All cases of viral hepatitis and sexually
transmitted infections (STIs) reported were identified during
voluntary screening. Regarding TB, active infection was
observed in six cases (four from Africa), four pulmonary and
two extra-pulmonary diseases; through the consequent
contact surveillance activities performed, no secondary cases
and four latent TB cases (all from Africa) were identified. Out
of the total examinations recorded, 192 (6.7%) ASs were
referred to hospitals (18.7% by public emergency ambulance)
for a second-level examination; 50 (26%) were then hospita-
lized for surgical (12), medical (12), psychiatric (9) and gynae-
cological/obstetrical (17) reasons.
Table 3 shows the results of the multiple logistic regression
analysis. Gender was the most significant predictor of ICD-10
diagnostic groups recorded. African origin was predictive of
cardiovascular and infectious diseases and slightly predictive
of pregnancy-related disorders. Higher mean age was positively
associated with cardiovascular diseases and illness related to
external causes. Non-smokers were protected against cardio-
vascular and respiratory diseases, while teetotallers were pro-
tected against digestive, nervous, musculoskeletal/connective
tissue diseases. Marital status was predictive only for genito-
urinary diseases; education (but not the mean years of school-
ing) was predictive of the ICD-10 group related to pregnancy,
childbirth and puerperium. The occupation in the birth
country was never a disease predictor.
Infectious diseases voluntary screening
Screening of infectious diseases (HBV, HCV, HIV, syphilis)
was restricted to adults and voluntary based. Among the 729
adult ASs examined, 347 (47.6%), 77.8% males, underwent
the screening and the number of tests carried out related to a
single infection has been different: 168 ASs accepted to
perform VDRL; 135 TPHA; 311 HIV-Ab; 334 HBsAg and
HBs-Ab; and 322 HCV-Ab tests. No gender-related differ-
ences were observed in accepting the voluntary screening.
The mean age was 29.8 (+7.9) years for the whole screened
population. West Africa was the main area of birth (35.4%;
n ¼ 123), followed by South Asia (24.2%; n ¼ 84) and East
Africa (21.9%; n ¼ 76). Data on education, marital status, oc-
cupation in the birth country and tobacco/alcohol consump-
tion were reported, respectively, for 231 (66.6%), 298
(85.9%), 268 (77.2%) and 151 (43.5%) screened participants.
Notably, the majority was schooled (88.3%), unmarried
(61.7%) and employed (82.8%). Regarding tobacco and
alcohol consumption, 38 (25.2%) participants reported
tobacco smoking (92.1% males) with an average of 11.2
(+7.3) cigarettes/day, 16 (10.6%) to consume alcohol daily
(81.2% males) and 6 (11.1%) to consume both regularly.
TPHA was positive in seven male subjects (5.2%; 95% CI
2.5–10.3), five of them from Africa, all but one VDRL nega-
tives. Eleven ASs were HIV-infected (3.5%; 95% CI 1.2–6.2),
five men (1.6%; 95% CI 0.7–3.7) and six women (1.9%; 95%
CI 0.9–4.1), all from Africa. Eleven were HCV-Ab-positives
(3.4%; 95% CI 1.9–6), nine men (2.8%; 95% CI 1.5–5.2)
and two women (0.6%; 95% CI 0.2–2.2), five from Africa
(1.5%; 95% CI 0.7–3.6) and six from Asia (1.9%; 95% CI
0.8–4.0).
Concerning HBV infection, we found 33 ASs (9.9%; 95%
CI 7.1–13.5) infected with HBV (confirmed by HBV-DNA,
data not shown), 28 men (8.4%; 95% CI 5.9–11.8) and 5
women (1.5%; 95% CI 0.6–3.5). Among all tested groups,
West Africans showed the highest HBV prevalence (15.5%;
n ¼ 18/116). Moreover, 70 ASs (21%; 95% CI 17.1–25.9)
were HBV-exposed (HBsAg-negative and HBs-Ab-positive),
60 men (18%; 95% CI 14.4–22.7) and 10 women (3%; 95%
CI 1.6–5.5). Co-infections were found only in two cases,
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Table 2 Individual diagnosis on ASs (n ¼ 792) according to ICD-10 diagnostic groups (2843 medical diagnoses performed)
Diagnosis (ICD-10 classification) Total
n % M F
Diseases of the respiratory system (26.3%) 747 100 579 168
Acute upper respiratory infections 398 53.3 311 87
Other acute lower respiratory infections 173 23.2 120 53
Influenza and pneumonia 139 18.6 113 26
Other diseases of upper respiratory tract 28 3.7 27 1
Chronic lower respiratory diseases 9 1.2 8 1
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (11.9%) 340 100 232 108
Symptoms and signs involving the digestive system and abdomen 160 47.1 99 61
General symptoms and signs 125 36.8 88 37
Symptoms and signs involving the circulatory and respiratory systems 50 14.7 41 9
Symptoms and signs involving cognition, perception, emotional state and behaviour 5 1.5 4 1
Diseases of the digestive system (11.6%) 331 100 244 87
Diseases of oral cavity, salivary glands and jaws 151 45.6 112 39
Diseases of oesophagus, stomach and duodenum 104 31.4 80 24
Non-infective enteritis and colitis 40 12.1 33 7
Other diseases of intestines 25 7.6 14 11
Other (disorders of gallbladder, biliary tract and pancreas; appendix; hernia) 11 3.3 5 6
Certain infectious and parasitic diseases (9.5%) 269 100 221 48
Enteritis of infectious origin 75 27.9 67 8
Mycoses 55 20.4 38 17
Viral hepatitis 44 16.4 38 6
Pediculosis, acariasis and other infestations 35 13.0 30 5
Infections with a predominantly sexual mode of transmission 17 6.3 16 1
Viral infections characterized by skin and mucous membrane lesions 17 6.3 14 3
Human immunodeficiency virus (HIV) disease 11 4.1 5 6
Tuberculosis (latent and active) 10 3.7 9 1
Other (helminthiasis; bacterial, viral and other infectious agents) 5 1.9 4 1
Diseases of the musculoskeletal system and connective tissue (9.3%) 264 100 221 43
Dorsopathies 153 58.0 114 39
Other disorders of the musculoskeletal system and connective tissue 50 18.9 49 1
Arthropathy 49 18.6 46 3
Soft tissue disorders 12 4.5 12 0
Diseases of the nervous system (7.3%) 209 100 149 60
Episodic and paroxysmal disorders 209 100 149 60
Injury, poisoning and certain other consequences of external causes (6.5%) 185 100 151 34
Injuries (knee and leg; head; wrist and hand; ankle and foot; thorax; neck; shoulder and arm; abdomen, lumbar, pelvis) 159 33.0 132 27
Injuries involving multiple body regions 18 9.7 15 3
Poisoning by drugs, medicaments and biological substances 5 2.7 1 4
Burns and corrosions 3 1.6 3 0
Diseases of the skin and subcutaneous tissue (5.5%) 157 100 125 32
Dermatitis and eczema 60 38.2 50 10
Infections of the skin and subcutaneous tissue 58 36.9 44 14
Urticaria and erythema 30 19.1 23 7
Other (disorders of skin appendages; other disorders of the skin and subcutaneous tissue) 9 4.5 8 1
Diseases of the genitourinary system (4.1%) 117 100 53 64
Other disorders of the genitourinary system 39 33.3 25 14
Continued
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both African women (one HIV/HBV, one HBV/HCV).
Three HIV-infected and three HCV-infected individuals, all
males from Africa, were also serologically HBV-exposed.
Table 4 shows the bivariate association between socio-
demographic characteristics and screening tests results.
Higher mean age was statistically associated with TPHA,
HIV-Ab and HCV-Ab positivity. The geographic origin was
statistically significant only for HIV infection. No predictive
factors were found to be associated with HBV infection. For
all screening tests performed, no statistically significant differ-
ences were found for education, civil status, occupation in the
birth country, tobacco and alcohol consumption.
Discussion
Main finding of this study
The present study analyses data from the IHCF of the ASC of
Castelnuovo di Porto (Rome, Italy) during a 1-year period.
Our study population consisted of young and generally
healthy migrants, as previously found in other studies.6,9,10 In
Italy, there are no guidelines related to ASs health, thus their
medical examination and infectious diseases screening (in-
cluding TB) is not mandatory, but only recommended.
During the study period, 68.8% of hosted ASs requested a
medical examination, mostly in the first 3 months after their
arrival at the ASC. In order to monitor compliance and side
effects of prescribed therapies,11,12 a DOT approach was
applied.
The main diagnoses identified were diseases of respiratory
system (26.3%) and symptoms/signs not elsewhere classified
(11.9%). Infectious and parasitic diseases accounted for
9.5% of the diagnoses, the most frequent infections were: der-
matologic (n ¼ 107/269, 39.8%) and enteric (n ¼ 75/269,
27.9%), with 55% of the latest (n ¼ 41/75) relating to an inci-
dental food contamination. Table 5 compares the main ICD
diagnostic groups observed in our study with those observed
in other studies on ASs from Malta10 and Switzerland.13,14
The main diagnoses differences observed could be related to
population diversity, climatic condition of the host countries,
but also to the different organization of ASs reception
systems. In the Maltese study,10 85% of ASs came from East
Africa (13% in our population), while in the Swiss study,13,14
50% were from Eastern Europe (absent in our study). The
vast majority of ASs hosted in Castelnuovo di Porto and
in Malta ASCs reached the two countries through the
Mediterranean Sea after a long journey. The ASC of the
present study, although large, was overcrowded, while the ASCs
of Maltese and Swiss studies were significantly smaller. This
may explain the higher prevalence of respiratory diseases in
our study. Moreover, ASs reaching Italy by sea were referred
to the Castelnuovo di Porto ASC after a few weeks spent in
reception centres where primary care was available, including
treatment of dermatological disorders related to their travel
conditions—this could justify the higher prevalence of der-
matologic disorders of the Maltese10 and Swiss13 studies.
According to ICD-10 classification, ‘symptoms/signs not
elsewhere classified’ were significantly prevalent in our and in
the Maltese study (6.8%),10 but not in the Swiss study.13 This
difference could be explained by the longer follow-up of the
Swiss study (3 years) that probably has facilitated a more
appropriate diagnosis. The excess of ‘symptoms/signs not
elsewhere classified’ in our population compared with the
Maltese study could be linked to a weaker cultural mediation
service, which may have exacerbated post-migratory difficulties
and hampered the change of unhealthy lifestyles (i.e. tobacco/
alcohol consumption)15 that were associated with different
ICD-10 diagnostic groups (Table 3).
We reported a 0.2% prevalence of active TB disease and no
secondary cases were detected through the consequent sur-
veillance activities performed. The TB prevalence was higher,
Table 2 Continued
Diagnosis (ICD-10 classification) Total
n % M F
Non-inflammatory disorders of female genital tract 32 27.4 0 32
Urolithiasis 27 23.1 20 7
Other (diseases of male/female genital or pelvic organs; disorders of breast) 19 6.8 8 11
Othersa (7.9%) 224 100 139 85
Total 2843 100 2114 729
aInclude: Diseases of the eye and adnexa (2%); diseases of the circulatory system (1.5%); pregnancy, childbirth and the puerperium (1.4%); external causes
of morbidity (1.3%); diseases of the ear and mastoid process (1.2%); diseases of the blood and blood-forming organs and certain disorders involving the
immune mechanism (0.3%); endocrine, nutritional and metabolic diseases (0.1%); neoplasm (0.1%).
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Table 3 Multiple logistic regression analysis of predictive factors for ICD-10 diagnosis (n ¼ 2843) in ASs (n ¼ 792)




Age: OR for þ1 year of
age
Education: yes versus no Marital status: married
versus unmarried
Tobacco (daily)a: no versus
yes
Alcohol (1 alcoholic
unit/day)a: no versus yes
OR (CI) P-value OR (CI) P-value OR (CI) P-value OR (CI) P-value OR (CI) P-value OR (CI) P-value OR (CI) P-value
Infectious and
parasitic diseases





4.3 (1.1–16.73) 0.03 1.87 (0.55–6.32) 0.3 1.4 (1.2–2.08) 0.03 2.19 (0.34–14.1) 0.4 1.93 (0.71–5.26) 0.2 0.24 (0.13–0.73) 0.01 1.63 (0.32–8.45) 0.6
Diseases of
digestive system
1.31 (0.83–2.06) 0.2 0.73 (0.41–1.31) 0.3 1.01 (0.97–1.04) 0.7 1.45 (0.68–3.09) 0.3 0.84 (0.52–1.35) 0.5 0.98 (0.47–1.13) 0.2 0.43 (0.21–0.85) 0.01
Diseases of the
ear
0.27 (0.04–1.59) 0.1 1.18 (0.13–10.3) 0.9 0.99 (0.88–1.13) 0.9 3.17 (0.23–44.1) 0.4 0.45 (0.08–2.38) 0.3 2.96 (0.54–16.3) 0.2 0.53 (0.12–2.22) 0.4
Diseases of the
eye and annexa








1.08 (0.63–1.83) 0.7 0.29 (0.12–0.69) ,0.01 0.95 (0.91–1.78) 0.09 0.32 (0.12–1.85) 0.2 2.52 (0.36–4.64) 0.6 1.67 (0.9–3.08) 0.1 0.43 (0.17–0.76) 0.02
Diseases of the
nervous system
0.95 (0.51–1.78) 0.8 2.31 (1.09–4.88) 0.03 1.01 (0.96–1.06) 0.6 0.51 0.19–1.37) 0.1 0.67 (0.37–1.23) 0.1 0.55 (0.29–1.02) 0.1 0.43 (0.18–0.72) ,0.01
Diseases of the
respiratory system


















0.81 (0.48–1.37) 0.4 1.36 (0.76–2.45) 0.3 1.01 (0.97–1.04) 0.7 1.4 (0.63–3.14) 0.4 0.87 (0.53–1.43) 0.6 0.94 (0.56–1.58) 0.8 0.72 (0.4–1.31) 0.3
n.a., not applicable.
aData only on adult ASs (n ¼ 729).
bNote: In order to perform the multiple logistic regression analysis, we aggregated the ‘Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism’ with the ‘Diseases of
the circulatory system’, the ‘External causes of morbidity and mortality’ with the ‘Injury, poisoning and certain other consequences of external causes’ and we excluded from this analysis the two neoplasm diagnosis.
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Table 4 Bivariate association between socio-demographic characteristics of adult (18 years) ASs and results of the screening tests (n ¼ 347)
Variables TPHA HIV-Ab HBsAg Hbs-Ab HCV-Ab
Pos, n (%) Neg, n (%) P-value Pos, n (%) Neg, n (%) P-value Pos, n (%) Neg, n (%) P-value Pos, n (%) Neg, n (%) P-value Pos, n (%) Neg, n (%) P-value
Continenta
Africa 6 (6.1) 93 (93.9) 0.4 11 (5.2) 199 (94.8) 0.02 25 (11.3) 196 (88.7) 0.2 47 (21.7) 170 (78.3) 0.6 5 (2.3) 209 (97.7) 0.1
Asia 1 (2.9) 33 (97.1) 0 (0) 99 (100) 8 (7.3) 102 (92.7) 23 (20.9) 87 (79.1) 6 (5.7) 100 (94.3)
Gender
Male 7 (6.7) 98 (93.3) 0.1 5 (2.1) 236 (97.9) 0.1 28 (10.7) 234 (89.3) 0.3 60 (23.1) 200 (76.9) 0.1 9 (3.5) 245 (96.5) 0.8
Female 0 (0) 30 (100) 6 (8.6) 64 (91.4) 5 (6.9) 67 (93.1) 10 (14.3) 60 (85.7) 2 (2.9) 66 (97.1)
Mean age (+SD) 38.9+10.4 30.7+8 ,0.01 40.1+5.9 29+7.3 ,0.01 27.7+6.7 29.7+7.7 0.1 28.3+6.8 29.8+7.7 0.1 36+12.4 29.3+7.5 ,0.01
Education
Yes 5 (5.9) 80 (94.1) 0.6 7 (3.9) 174 (96.1) 0.9 17 (8.7) 178 (91.3) 0.3 31 (19.7) 155 (80.3) 0.5 7 (3.7) 180 (9.3) 0.3
No 0 (0) 3 (100) 1 (4.2) 23 (95.8) 4 (14.8) 23 (85.2) 4 (14.8) 23 (85.2) 0 (0) 27 (100)
Mean years (+SD) 9.3+6.6 8+5.2 0.5 7.8+6.4 7.8+5.2 0.9 6.7+5.5 7.8+5.2 0.1 7.2+5.3 7.8+5.2 0.3 7.5+6.2 7.8+5.2 0.8
Marital status
Married 4 (7.8) 47 (92.2) 0.3 7 (6.8) 96 (93.2) 0.08 9 (8.2) 101 (91.8) 0.3 18 (17.1) 87 (82.9) 0.3 4 (3.7) 104 (96.3) 0.9
Unmarried 3 (3.9) 75 (96.1) 4 (2.5) 158 (97.5) 21 (11.9) 156 (88.1) 38 (21.4) 140 (78.6) 6 (3.5) 166 (96.5)
Occupation
Farmer 0 (0) 13 (100) 0.4 1 (4.2) 23 (95.8) 0.2 4 (16.7) 20 (83.3) 0.2 7 (29.2) 17 (70.8) 0.2 2 (8.3) 22 (91.7) 0.6
Craftsmen 1 (3.7) 26 (96.3) 0 (0) 58 (100) 9 (13.5) 56 (86.5) 11 (16.9) 54 (83.1) 1 (1.6) 63 (98.4)
Professional 1 (33.3) 2 (66.7) 0 (0) 8 (100) 0 (0) 8 (100) 1 (14.3) 6 (85.7) 0 (0) 8 (100)
Student 0 (0) 8 (100) 1 (4) 24 (96) 5 (17.9) 23 (82.1) 2 (7.4) 25 (92.6) 1 (3.7) 26 (96.3)
Public employee 1 (.83) 11 (91.7) 1 (4) 24 (96) 1 (2.9) 25 (96.1) 8 (30.8) 18 (69.2) 1 (3.5) 25 (96.5)
Trader 2 (6.9) 27 (93.1) 6 (10) 54 (90) 3 (4.8) 59 (95.2) 11 (18) 50 (82) 4 (6.7) 56 (93.3)
Unemployed 1 (5.9) 16 (94.1) 2 (5) 38 (95) 4 (9.1) 40 (90.9) 11 (25.6) 32 (74.4) 1 (2.4) 41 (97.6)
Tobacco
Yes 2 (8.3) 22 (91.7) 0.5 3 (3.1) 95 (96.9) 0.9 9 (8.2) 191 (91.8) 0.6 24 (22.4) 83 (77.6) 0.06 2 (1.9) 106 (98.1) 0.7
No 1 (16.7) 5 (83.3) 1 (2.8) 35 (97.2) 2 (5.6) 34 (94.4) 3 (8.3) 33 (91.7) 1 (2.8) 35 (97.2)
Alcohol
Yes 1 (4.4) 22 (95.6) 0.06 4 (3.3) 116 (96.7) 0.4 11 (8.4) 119 (91.5) 0.2 25 (19.5) 103 (80.5) 0.9 3 (2.3) 127 (97.7) 0.5
No 2 (28.6) 5 (71.4) 0 (0) 14 (100) 0 (0) 16 (100) 2 (20) 12 (80) 0 (0) 14 (100)
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compared with the Maltese study (0.004%)10 and lower than
an Italian study on ASs (0.8%) based on active screening ap-
proach.16 No malaria cases were found. Overall, 56 active in-
fectious diseases (2% of total diagnoses reported) were
detected through the voluntary screening. HBV infection
prevalence in African groups was similar to that reported in
the literature,17 including studies on ASs.18,19
Based on their ages and year of vaccine introduction into
their birth countries, none of screened ASs could have
received a routine childhood HBV-vaccination.20 One out of
three screened participants had a serologic pattern of
HBV-infection/exposure, confirming a high viral circulation
in their birth countries.17 An immunization policy for HBV
infection among ASs is a public health need. HCV seropreva-
lence in the African group of participants was similar to that
observed in a systematic review on global HCV burden,21 but
different from that described in other studies on African ASs
in Italy (4.3%)18 and Malta (0.6%).19 The HBV and HCV
seroprevalence on Asian ASs were higher than that reported
in large systematic reviews.17,21 The HIV prevalence was
slightly higher than that from other studies on ASs,18,22 but
no opportunistic infections were recorded. The observed
prevalence of syphilis (latent/active) confirmed a significant
spread in our study population. The bivariate analysis per-
formed, looking for an association between socio-
demographic characteristics and screening results, showed a
statistically significant association of the mean age with
TPHA, HIV and HCV positivity and of the African origin
with HIV infection, while no associations were found for
HBV-infection/exposure.
What is already known on this topic
The number of ASs has increased over the most recent
years1 – 3 and, although the vast majority is hosted in develop-
ing countries,1,2 are increasingly those who try to reach EU
countries to seek asylum. Healthcare services for ASs in EU
countries appear not to be homogeneous and are often based
on minimum standards.23 Data on ASs communicable dis-
eases burden are heterogeneous.24 Available studies on ASs
are mainly oriented on infectious diseases burden and only a
few focused on their global health profile. ASs are a vulner-
able population because of the push factors (conflicts, tor-
tures, abuses, etc.) of their migration process23,25 – 27 and
published data on their health status are limited.15 Social di-
versity, language barriers and cultural beliefs (including
health-related)6 may influence the acceptance of preventive
care, such as screening28 and post-migration difficulties (i.e.
uncertainty of their status, length of asylum procedure, after-
maths of conflicts, etc.) may be responsible of an over-request
of healthcare assistance.29,30
What this study adds
The present study provides a comprehensive picture of the
health profile and independent diseases’ predictors among
ASs living in a big ASC in Italy, where data are limited. Our
AS population was affected by diseases related to environ-
mental factors (i.e. poor hygiene and overcrowding living con-
ditions) as respiratory (i.e. acute infections) and infectious
diseases (i.e. enteritis, skin infections). The observed excess of
non-specific physical symptoms/signs could be related to a
short observation period and/or to post-migratory difficul-
ties. Concerning screened infectious diseases, their prevalence
was mainly related to birth countries. Thus, we think that
interventions should be implemented in ASC in order to: (i)
improve reception systems (i.e. avoiding overcrowding living
conditions); (ii) strengthen cultural mediation support to miti-
gate the impact of post-migration factors on health status and
promote a proper use of healthcare facilities; (iii) facilitate vol-
untary screening of infectious diseases endemic in birth coun-
tries to preserve individual and public health; (iv) promote
Table 5 Comparison of observed main ICD diagnostic groups with
studies on ASs from Malta and Switzerland (psychiatric disorders not
included)


































































aData from this study were originally based on ICD-9 classification and
have been re-elaborated according to ICD-10 diagnostic groups in order
to be comparable with the other two studies.
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health awareness and prevention (i.e. immunization) cam-
paigns tailored to different AS cultures. Finally, we wish for a
coherent social– legal and health approach among EU coun-
tries tailored on AS health needs, along with recognized pro-
fessional training for cultural mediators strengthening their
ability to support the migrant and health personnel.
Limitations of this study
Our study has some limitations. The lack of systematic cul-
tural mediation support could have caused a reduced diagnos-
tic accuracy because of language barriers. Moreover, we have
not considered psychiatric disorders because they have been
managed outside the IHCF by an external team of specialists.
Also, psychiatric examinations were not recorded, excluding a
possible comparison with our data. Finally, for the infectious
diseases detected by voluntary screening, we cannot establish
the timing of infection.
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